Anika Therapeutics (ANIK) Inventory Average (2011 - 2026)

Anika Therapeutics (ANIK) has 16 years of Inventory Average data on file, last reported at $20.8 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $20.8 million, down 7.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.8 million (down 7.8% YoY), and the FY2025 annual result was $21.3 million, down 11.69% from the prior year.
• Inventory Average advanced to $20.8 million in Q1 2026 per ANIK's latest filing, from $17.5 million in the prior quarter.
• Over five years, Inventory Average peaked at $50.4 million in Q2 2024 and troughed at $16.6 million in Q3 2025.
• A 5-year average of $33.3 million and a median of $35.6 million in 2022 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2024 and 2025: Inventory Average grew 20.2% in 2024, then slumped 63.55% in 2025.
• A 5-year view of Inventory Average shows it stood at $38.5 million in 2022, then slipped by 11.49% to $34.1 million in 2023, then decreased by 6.92% to $31.7 million in 2024, then slumped by 44.72% to $17.5 million in 2025, then rose by 18.69% to $20.8 million in 2026.
• Business Quant data shows ANIK's Inventory Average at $20.8 million in Q1 2026, $17.5 million in Q4 2025, and $16.6 million in Q3 2025.